Patents by Inventor Craig Crowley

Craig Crowley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR HEMATOPOIETIC ORIGIN
    Publication number: 20170362318
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: January 13, 2017
    Publication date: December 21, 2017
    Inventors: Craig Crowley, Frederic J. De Sauvage, Dan L. Eaton, Allen Ebens, JR., Kristi Elkins, Jo-Anne S. Hongo, Jagath Reddy Junutula, Andrew Polson, Sarajane Ross, Victoria Smith, Richard L. Vandlen, Bing Zheng
  • Compositions and methods for the treatment of tumor of hematopoietic origin
    Patent number: 9085630
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Grant
    Filed: June 6, 2011
    Date of Patent: July 21, 2015
    Assignee: Genentech, Inc.
    Inventors: Craig Crowley, Frederic J. de Sauvage, Dan L. Eaton, Allen Ebens, Jr., Andrew Poison, Victoria Smith
  • Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
    Publication number: 20130149298
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: June 6, 2011
    Publication date: June 13, 2013
    Inventors: Craig Crowley, Frederic J. de Sauvage, Dan L. Eaton, Allen Ebans, JR., Andrew Poison, Victoria Smith
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
    Publication number: 20110206658
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: October 12, 2010
    Publication date: August 25, 2011
    Inventors: Craig Crowley, Frederic J. de Sauvage, Dan L. Eaton, Allen Ebens, JR., Kristi Elkins, Jo-Anne S. Hongo, Jagath Reddy Juntula, Andrew Polson, Sarajane Ross, Victoria Smith, Richard L. Vandlen, Bing Zheng
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC
    Publication number: 20110070243
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: September 9, 2010
    Publication date: March 24, 2011
    Inventors: CRAIG CROWLEY, FREDERIC J. DE SAUVAGE, DAN L. EATON, ALLEN EBENS, JR., KRISTI ELKINS, JO-ANNE S. HONGO, JAGATH REDDY JUNUTULA, ANDREW POLSON, SARAJANE ROSS, VICTORIA SMITH, RICHARD L. VANDLEN, BING ZHENG
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
    Publication number: 20110045005
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: April 7, 2010
    Publication date: February 24, 2011
    Inventors: Craig Crowley, Frederic J. de Sauvage, Dan L. Eaton, Allen Ebens, JR., Andrew Polson, Victoria Smith
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
    Publication number: 20110042260
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: August 12, 2010
    Publication date: February 24, 2011
    Inventors: Craig Crowley, Frederic J. de Sauvage, Dan L. Eaton, Allen Ebens, JR., Jo-Anne S. Hongo, Andrew Polson, Sarajane Ross, Victoria Smith, Richard L. Vandlen
  • Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
    Publication number: 20090068178
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: January 31, 2008
    Publication date: March 12, 2009
    Applicant: Genentech, Inc.
    Inventors: Craig Crowley, Frederic J. de Sauvage, Dan L. Eaton, Allen Ebens, JR., Kristi Elkins, Jo-Anne S. Hongo, Jagath Reddy Junutula, Andrew Polson, Sarajane Ross, Victoria Smith, Richard L. Vandlen, Bing Zheng
  • Compositions and methods for the treatment of tumor of hematopoietic origin
    Publication number: 20090053226
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: March 27, 2008
    Publication date: February 26, 2009
    Inventors: Craig Crowley, Frederic J. de Sauvage, Dan L. Eaton, Allen Ebens, JR., Andrew Polson, Victoria Smith
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
    Publication number: 20070207142
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: August 3, 2006
    Publication date: September 6, 2007
    Applicant: Genentech, Inc.
    Inventors: Craig Crowley, Frederic de Sauvage, Dan Eaton, Allen Ebens, Jo-Anne Hongo, Andrew Polson, Sarajane Ross, Victoria Smith, Richard Vandlen
  • Expression Vectors and Methods
    Publication number: 20070054303
    Abstract: Vectors and methods for efficient isolation of recombinant cells expressing high levels of a desired protein are provided. The vectors comprise an amplifiable selectable gene, a fluorescent protein gene, and a gene encoding a desired product in a manner that optimizes transcriptional and translational linkage.
    Type: Application
    Filed: September 25, 2006
    Publication date: March 8, 2007
    Applicant: Genentech, Inc.
    Inventors: Vanessa Chisholm, Craig Crowley, Lynne Krummen, Yu-Ju Meng, Amy Shen
  • Expression Vectors and Methods
    Publication number: 20070037254
    Abstract: Vectors and methods for efficient isolation of recombinant cells expressing high levels of a desired protein are provided. The vectors comprise an amplifiable selectable gene, a fluorescent protein gene, and a gene encoding a desired product in a manner that optimizes transcriptional and translational linkage.
    Type: Application
    Filed: September 25, 2006
    Publication date: February 15, 2007
    Applicant: Genentech, Inc.
    Inventors: Vanessa Chisholm, Craig Crowley, Lynne Krummen, Yu-Ju Meng
  • Immunoglobulin variants and uses thereof
    Publication number: 20060034835
    Abstract: The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
    Type: Application
    Filed: June 7, 2005
    Publication date: February 16, 2006
    Applicant: Genentech, Inc.
    Inventors: Camellia Adams, Andrew Chan, Craig Crowley, Henry Lowman, Gerald Nakamura, Leonard Presta
  • Immunoglobulin variants and uses thereof
    Publication number: 20060024300
    Abstract: The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
    Type: Application
    Filed: July 26, 2005
    Publication date: February 2, 2006
    Applicant: Genentech, Inc.
    Inventors: Camellia Adams, Andrew Chan, Craig Crowley, Henry Lowman, Gerald Nakamura, Leonard Presta
  • Compositions and methods for the treatment of tumor of hematopoietic origin
    Publication number: 20050238650
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: November 16, 2004
    Publication date: October 27, 2005
    Inventors: Craig Crowley, Frederic de Sauvage, Dan Eaton, Allen Ebens, Andrew Polson, Victoria Smith
  • Expression vectors and methods
    Publication number: 20050005310
    Abstract: Vectors and methods for efficient isolation of recombinant cells expressing high levels of a desired protein are provided. The vectors comprise an amplifiable selectable gene, a fluorescent protein gene, and a gene encoding a desired product in a manner that optimizes transcriptional and translational linkage.
    Type: Application
    Filed: November 14, 2003
    Publication date: January 6, 2005
    Inventors: Vanessa Chisholm, Craig Crowley, Lynne Krummen, Yu-Ju Meng, Amy Shen